Drug Safety Information for CELONTIN (Methsuximide)

Adverse Drug Reactions for CELONTIN* (Methsuximide)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with CELONTIN
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Convulsion22
2Drug interaction6
3Fall6
4Drug ineffective5
5Somnolence5
6Dizziness5
7Condition aggravated5
8Feeling abnormal4
9Lethargy4
10Vomiting4
11Malaise3
12Product quality issue3
13Drug level decreased3
14Balance disorder3
15Fatigue3
16Anticonvulsant drug level decreased3
17Coma3
18Vertigo2
19General physical health deterioration2
20Pneumonia2

* This side effect also appears in "Top 10 Side Effects of CELONTIN " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking CELONTIN
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Epilepsy58
2Convulsion55
3Product used for unknown indication13
4Partial seizures8
5Myoclonic epilepsy7
6Petit mal epilepsy6
7Ill-defined disorder2
8Osteoarthritis2
9Grand mal convulsion2

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for CELONTIN

Total Reports Filed with FDA: 254


Number of FDA Adverse Event Reports by Patient Age for CELONTIN

Total Reports Filed with FDA: 254*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Methsuximide (Petinutin, Celontin)

Charts are based on 254 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and CELONTIN Reviews and Review Summary .

Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.